1. A systems biology approach towards novel biomarkers of atherosclerosis and validation of fatty acid-binding protein 4 (FABP4) as prognostic and diagnostic biomarker for coronary artery disease. Issue 1 (July 2015) Authors: Gawinecka, J.; Reiser, H.; Klingenberg, R.; Hof, D.; Marques-Vidal, P.M.; Vollenweider, P.M.; Hek, D.; Rodondi, N.; Mach, F.; Lüscher, T.F.; von Eckardstein, A. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-apoA-1 autoantibodies increase mouse atherosclrotic plaque vulnerability, myocardial necrosis and mortality trough TLR2 and TLR4-mediated pathways. Issue 1 (July 2015) Authors: Montecucco, F.; Braunersreuther, V.; Burger, F.; Lenglet, S.; Pelli, G.; Carbone, F.; Fraga-Silva, R.; Stergiopulos, N.; Monaco, C.; Mueller, C.; Pagano, S.; Dallegri, F.; Mach, F.; Vuilleumier, N. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients. (August 2018) Authors: Satta, N.; Pagano, S.; Montecucco, F.; Gencer, B.; Mach, F.; Kaiser, L.; Calmy, A.; Vuilleumier, N. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti-apolipoprotein A1 (APOA1) autoantibodies disrupt the cholesterol pathway via SREBP-2 and decrease circulating MIR-33A in hypercholesterolaemic children. (August 2018) Authors: Sabrina, P.; Magenta, A.; D'Agostino, M.; Martino, F.; Barillà, F.; Satta, N.; Frias, M.; Gencer, B.; Mach, F.; Vuilleumier, N. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti-apolipoprotein A1 autoantibodies induce tissue factor activity and expression: a role in atherothrombosis. Issue 1 (July 2015) Authors: Pagano, S.; Satta, N.; Virzi, J.; Mannic, T.; Roux-Lombard, P.; Mach, F.; Montecucco, F.; Vuilleumier, N. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anti-apolipoprotein A1 autoantibodies induce tissue factor activity and expression: a role in atherothrombosis. Issue 1 (July 2015) Authors: Pagano, S.; Satta, N.; Virzi, J.; Mannic, T.; Roux-Lombard, P.; Mach, F.; Montecucco, F.; Vuilleumier, N. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Antibodies against apolipoprotein a-1 as disruptors of cellular cholesterol homeostasis promoting foam cell formation. (December 2020) Authors: Pagano, S.; Magenta, A.; D'Agostino, M.; Martino, F.; Barillà, F.; Satta, N.; Frias, M.A.; Ronca, A.; Mach, F.; Gencer, B.; Favari, E.; Vuilleumier, N. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Antibodies against the C-terminus of apolipoprotein A-1 as predictors of death in the general population but not as therapeutic targets actionable through cognate peptides immunomodulation. (December 2020) Authors: Vuilleumier, N.; Antiochos, P.; Pagano, S.; Marques-Vidal, P.; Virzi, J.; Satta, N.; Hartley, O.; Brandt, K.J.; Burger, F.; Montecucco, F.; Waeber, G.; Mach, F. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Anti‐apolipoprotein A‐1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis. (11th October 2012) Authors: Wick, P. A.; Mombelli, A.; Pagano, S.; Moren, X.; Giannopoulou, C.; Mach, F.; Roux‐Lombard, P.; Vuilleumier, N. Journal: Journal of periodontal research Issue: Volume 48:Number 3(2013:Jun.) Page Start: 350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Autoantibodies directed against apolipoprotein-A1 as a potential contributor to non-alcoholic fatty liver disease. (August 2021) Authors: Pagano, S.; Alfaiate, D.; Juillard, C.; Frias, M.; Magenta, A.; Martino, F.; Sciacqua, A.; Succurro, E.; Burger, F.; Brandt, K.J.; Andreozzi, F.; Mach, F.; Perticone, M.; Vuilleumier, N. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗